Javier De La Cruz

Dr. Javier De La Cruz


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2018 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AMAlicia Muñoz-Gallego
Alicia Muñoz-Gallego
JCJavier De La Cruz
Javier De La Cruz
MRMartín Rodríguez-Salgado
Martín Rodríguez-Salgado
JTJosé L Torres-Peña
José L Torres-Peña
BDBeatriz De-Lucas-Viejo
Beatriz De-Lucas-Viejo
PTPilar Tejada-Palacios
Pilar Tejada-Palacios

1 May 2021 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
GCG. Cornec
G. Cornec
GDG. Drewnowski
G. Drewnowski
IDI. Desguerre
I. Desguerre
PTP. Toullet
P. Toullet
JBJ. Boivin
J. Boivin
SBS. Brochard
S. Brochard

10 February 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
GCGwenaël Cornec
Gwenaël Cornec
SBSylvain Brochard
Sylvain Brochard
GDGaelle Drewnowski
Gaelle Drewnowski
IDIsabelle Desguerre
Isabelle Desguerre
PTPhilippe Toullet
Philippe Toullet
JCJavier De La Cruz
Javier De La Cruz
Background and Aims: The provision of coordinated and multidisciplinary rehabilitation programs that adapt to the individual with cerebral palsy (CP) evolving rehabilitation needs throughout the different phases of life is highly challenging for healthcare systems. The aim of this study was to report the changes in motor rehabilitation (MR) environmental factors, service use and patient outcomes between children and adults with cerebral palsy and to identify if changes took place earlier or later than the standard division between pediatric and adult healthcare systems at 18 years. Methods: We used data from the French ESPaCe survey to select a set of indicators for MR environmental factors, service use and patient outcomes, highlighted by patients and families in previous studies. We then compared the distribution of the indicator data between children and adults, as well as between four transition age groups: children under 12, adolescents up to 17 years, young adults, and adults over 25 years of age. We estimated odds ratios adjusted for motor involvement, associated impairments and informant type. Results: A total of 997 respondents over 2 years of age were included in this study (484 children and 513 adults). Finding an available physiotherapist was very difficult for almost half of the children, and a greater proportion of adolescents and adults. Physiotherapy was provided in a private outpatient practice for twice as many adults over 25 years as children and adolescents. The weekly amount of physical therapy decreased as outpatient practice increased. Multidisciplinary rehabilitation decreased sharply from adolescence and was halved at adulthood. Satisfaction with the MR program decreased from childhood into adolescence and adulthood. Perceived impact of physiotherapy on people with CP and their main carers were less positive in adolescents. Conclusions: Healthcare policies should focus on accessibility issues at all ages, consider adolescents as a specific population, consider a wide transition phase (12–25 yo) and maintain a multidisciplinary approach at adulthood. There is a strong need for national rehabilitation strategies for individuals with CP.

27 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
Joaquin Martinez-LopezJoaquin Martinez-Lopez
Joaquin Martinez-Lopez
JCJavier De La Cruz
Javier De La Cruz
RMRodrigo Gil Manso
Rodrigo Gil Manso
AAAdrián Alegre
Adrián Alegre
JOJavier Ortiz
Javier Ortiz
JSJULIO GARCIA SUAREZ
JULIO GARCIA SUAREZ
Mortality rates for COVID-19 have declined over time in the general population, but data in patients with hematologic malignancies are contradictory. We identified independent prognostic factors for COVID-19 severity and survival in unvaccinated patients with hematologic malignancies, compared mortality rates over time and versus non-cancer inpatients, and investigated post COVID-19 condition. Data were analyzed from 1166 consecutive, eligible patients with hematologic malignancies from the population-based HEMATO-MADRID registry, Spain, with COVID-19 prior to vaccination roll-out, stratified into early (February–June 2020; n = 769 (66%)) and later (July 2020–February 2021; n = 397 (34%)) cohorts. Propensity-score matched non-cancer patients were identified from the SEMI-COVID registry. A lower proportion of patients were hospitalized in the later waves (54.2%) compared to the earlier (88.6%), OR 0.15, 95%CI 0.11–0.20. The proportion of hospitalized patients admitted to the ICU was higher in the later cohort (103/215, 47.9%) compared with the early cohort (170/681, 25.0%, 2.77; 2.01–3.82). The reduced 30-day mortality between early and later cohorts of non-cancer inpatients (29.6% vs. 12.6%, OR 0.34; 0.22–0.53) was not paralleled in inpatients with hematologic malignancies (32.3% vs. 34.8%, OR 1.12; 0.81–1.5). Among evaluable patients, 27.3% had post COVID-19 condition. These findings will help inform evidence-based preventive and therapeutic strategies for patients with hematologic malignancies and COVID-19 diagnosis.

30 May 2022 in The Lancet Haematology
Verified
Journal Article
Closed access
POPablo L Ortiz-Romero
Pablo L Ortiz-Romero
LJLidia Maroñas Jiménez
Lidia Maroñas Jiménez
CMCristina Muniesa
Cristina Muniesa
TETeresa Estrach
Teresa Estrach
OSOctavio Servitje
Octavio Servitje
MPMiguel Ángel Piris Pinilla
Miguel Ángel Piris Pinilla

24 May 2020 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
AMAlicia Muñoz-Gallego
Alicia Muñoz-Gallego
JCJavier De La Cruz
Javier De La Cruz
MRMartín Rodríguez-Salgado
Martín Rodríguez-Salgado
JTJosé L. Torres-Peña
José L. Torres-Peña
JSJavier Sambricio
Javier Sambricio
PTPilar Tejada-Palacios
Pilar Tejada-Palacios
Background: Assessment of interobserver reproducibility and interocular symmetry using optical coherence tomography (OCT)–based measurements of the macular ganglion cell complex (GCC) in healthy children facilitates interpretation of OCT data. We assessed the interobserver reproducibility and interocular symmetry of GCC and evaluated candidate determinants. Methods: This was a cross-sectional study performed in a primary and tertiary health-care setting. A total of 126 healthy participants aged 5 to 18 years were eligible. GCC scans were performed by 4 operators using the Topcon 3D OCT-2000 device. Intraclass correlation coefficients (ICCs) were used to estimate reproducibility and symmetry. Cut-off points for symmetry were defined as the 95th percentile of the absolute interocular difference for 6 GCC parameters. Percentile distributions of interocular difference were generated based on age and difference in absolute interocular spherical equivalent (SE). Results: The reproducibility ICC ranged from 0.96 to 0.98 for all 6 GCC parameters. Cut-off points for interocular symmetry of the superior and inferior quadrants and total macular retinal nerve fibre layer thickness (mRNFL) and macular ganglion cell layer-inner plexiform layer thickness were 3.5, 4.5, 3.0, 3.0, 2.5, and 2.5 μm respectively. A positive association was observed between the absolute interocular difference of SE and superior and total mRNFL symmetry values (p = 0.047 and p = 0.040, respectively). Conclusions: OCT measurements of GCC in healthy children show excellent reproducibility. Interocular differences in SE should be assessed when mRNFL differences exceed the 95% cut-off. These findings can contribute to establish reference values for interocular symmetry in paediatric GCC parameters.